| 1997 |
GNGT2 encodes the cone-specific G-protein gamma subunit (Gγc) that is specifically localized in cone photoreceptors, as demonstrated by immunohistochemical staining with anti-Gγc antibodies. The gene has a three-exon, two-intron structure with intron splice sites similar to the rod Gγ1 gene (GNGT1), and the protein is implicated in coupling the cone visual pigment to phosphodiesterase. |
Immunohistochemistry, nucleotide sequence analysis, fluorescence in situ hybridization |
Genomics |
High |
9286705
|
| 2012 |
Phylogenetic and synteny analyses established that GNGT2 is one of three gamma subunit genes in mammals (alongside GNGT1 and GNG11) that expanded during early vertebrate tetraploidizations. GNGT2 encodes the cone-specific transducin gamma subunit, forming the cone transducin heterotrimer with GNAT2 and GNB3. |
Phylogenetic analysis and synteny comparison across vertebrate genomes |
Genomics |
Medium |
22814267
|
| 2015 |
In zebrafish, gngt2a and gngt2b (duplicates from teleost tetraploidization) undergo spatial subfunctionalization: gngt2b expression is restricted to the dorsal and medial retina, while gngt2a is expressed ventrally. Additionally, gngt2b is transiently expressed in the pineal complex during ontogeny, showing partial temporal subfunctionalization. |
In situ hybridization, ontogenetic expression analysis in zebrafish retina and pineal complex |
PloS one |
Medium |
25806532
|
| 2016 |
Gngt2 (cone transducin γ) protein is expressed in the embryonic mouse retina beginning at embryonic day 13.5, restricted to the outer neuroblastic layer coinciding with the earliest stages of cone histogenesis, well before opsin gene expression. This establishes GNGT2 as an early cone differentiation marker with potential embryonic G-protein signaling roles beyond visual transduction. |
Immunohistochemistry and qPCR in embryonic and early postnatal mouse retina |
Molecular vision |
Medium |
28031694
|
| 2022 |
Transgenic rescue experiments in Gγ1-deficient rods demonstrated that Gγc (GNGT2) can functionally substitute for Gγ1 to restore rod phototransduction, Gαt1 expression, photosensitivity, and light-induced Gαt1 translocation from outer to inner segments, indicating that farnesylated Gγ subunits are largely interchangeable in supporting transducin function in rods. |
Transgenic mouse generation, electroretinography, single-rod recordings, immunohistochemistry, Western blotting |
PloS one |
High |
35939447
|
| 2022 |
Loss of both Abi3 and Gngt2 (which overlap at the same genomic locus) in mice leads to upregulation of Trem2, Plcg2, and Tyrobp and induction of an AD-associated neurodegenerative microglial gene signature even without AD neuropathology. In APP amyloid mice, Abi3-Gngt2 deficiency causes age- and gene dose-dependent reduction in Aβ deposition, while in tau models it exacerbates tauopathy and astrocytosis, demonstrating roles in microglial inflammatory responses and AD pathology modulation. |
Knockout mouse models, bulk RNAseq, RNAscope in situ hybridization, in vitro culture assays for ABI3 phosphorylation |
Alzheimer's research & therapy |
Medium |
35897046
|
| 2022 |
A CRISPR/Cas9-tagged GNGT2-T2A-mCherry human embryonic stem cell reporter line confirmed that GNGT2 faithfully marks cone photoreceptors throughout their differentiation in vitro in optic vesicle-like structures, recapitulating normal fetal cone expression. Live imaging revealed significant migratory activity of GNGT2-expressing cones during in vitro differentiation. |
CRISPR/Cas9 genome editing, 3D optic vesicle organoid differentiation, live fluorescence imaging |
Stem cells (Dayton, Ohio) |
Medium |
35293574
|
| 2025 |
Short promoter sequences (≤840 bp) derived from the GNGT2 gene drive robust and photoreceptor-specific transgene expression when delivered via AAV to the subretinal space of canine inherited retinal degeneration models at mid and late disease stages, establishing GNGT2 regulatory elements as functional cone-specific promoters for gene therapy. |
Dual-luciferase assays, AAV subretinal delivery in canine IRD models, RNA in situ hybridization, qPCR |
Molecular therapy |
Medium |
40405464
|